( SCOPE中國臨床開發夥伴論壇 )

The SCOPE China Clinical Development Partnering Forum

2020年2月18日(二) 14:00~17:00 CHI’s SCOPE Summit in Orlando

The new China Partnering Forum at SCOPE provides a focused forum where Global and Chinese-based pharmaceutical companies, biotech companies, academic research centers, CROs, consultancies and other service providers involved in the conduct of drug development and clinical trials can share best practices for developing and bringing new therapies to market here in the West and in China. The stakeholders may be US or European sponsors interested in partnering with up-and-coming Chinese biotech companies, or they may be Chinese innovators looking for US-based CROs or licensing partners to expand their market and reach. This is not simply about “outsourcing”! This is about research-based innovators on both sides trying to figure out a win-win and trying to help one another navigate a two-way partnership. The forum will feature case studies, “how to” panel discussions, and networking. The atmosphere will be casual and interactive, though the topic is very important and somewhat complicated at this moment in time. Speaking proposals and panel proposals are being accepted, but they must include actual best practices and leaders who can offer accurate advice on how best to find partners on both sides.


PROGRAM COMMITTEE & FACULTY

Jane Fang, MD, MS, Director, Leader of Digital Clinical Innovations, RWD/RWE for Clinical Trials, AstraZeneca

Sean Zhao, PhD, Head, US Patient Safety, AstraZeneca

Yue Yang, PhD, Director, International Center for Food and Drug Policy and Legal Research, Shenyang Pharmaceutical University

Amanda Fu, MD, MBA, Founder and CEO, RedBud Pharma

Walt Cao, PhD, President, Zeta Therapeutics, Inc.

Micah Lieberman, Executive Director, Conferences, Cambridge Healthtech Institute (CHI)

Marina Filshtinsky, MD, Executive Director, Conferences, Cambridge Healthtech Institute (CHI)

Dan Zhang, CEO, Fountain Medical Development Ltd.

Chuck Bradley, Vice President, Clinical Development, FibroGen, Inc.

Bill Byrom, Vice President, Product Strategy and Innovation, Signant Health

Xiaoyao Conny Mo, MD, Partner, Lead of Medical Safety Consulting, Beijing Renheguangtong (RHGT) Co., Ltd.

Wendy Wang, PhD, MD, Managing Director, Linical Accelovance Group

AGENDA

2020年2月18日(二) 14:00~17:00

CHINESE PHARMA INDUSTRY CHALLENGES AND OPPORTUNITIES & NEW CHINESE DRUG DEV REGULATIONS

1:30 pm Registration

2:00  Organizers’ Welcome
Micah Lieberman, Executive Director, Conferences, Cambridge Healthtech Institute (CHI)
Marina Filshtinsky, MD, Executive Director, Conferences, Cambridge Healthtech Institute (CHI)

2:05  Chinese Pharmaceutic Industry and Its Future Direction: Challenges and Opportunities
Cao_WaltWalt Cao, PhD, President, Zeta Therapeutics,Inc.


2:25  China R&D Innovation Strategy under New Drug Development and Regulatory Environment: The Newly Passed Drug Administration Law of the People’s Republic of China
Yang_YueYue Yang, PhD, Director, International Center for Food and Drug Policy and Legal Research, Shenyang Pharmaceutical University


CONDUCTING TRIALS IN CHINA & COMPARE AND CONTRAST HOW CROS IN CHINA & US OPERATE IN DRUG DEVELOPMENT

2:45  Opportunities and Challenges of Conducting Clinical Trials in China (vs North America and Europe)
Fu_AmandaAmanda Fu, MD, MBA, Founder and CEO, RedBud Pharma


3:05  Panel Discussion: Compare/Contrast CROs in China & CROs in US – How We Operate in Drug Development

Fang_JaneModerator: Jane Fang, MD, MS, Director, Leader of Digital Clinical Innovations, RWD/RWE for Clinical Trials, AstraZeneca


Zhang_DanDan Zhang, CEO, Fountain Medical Development Ltd.


Fu_AmandaAmanda Fu, MD, MBA, Founder and CEO, RedBud Pharma


Yang_YueYue Yang, PhD, Director, International Center for Food and Drug Policy and Legal Research, Shenyang Pharmaceutical University


3:35  Networking Break

US-CHINA INDs and NDAs & ESTABLISHING CHINA-US ALLIANCES

4:05  US-China Comparison on IND, NDA and Conduct of Clinical Trials
Zhang_DanDan Zhang, MD, Executive Chairman, Fountain Medical Development Ltd.


4:20  Panel Discussion: How to Establish China and US Collaborative Alliance in Drug Development

Wang_WendyModerator: Wendy Wang, PhD, MD, Managing Director, Linical Accelovance Group


Cao_WaltWalt Cao, PhD, President, Zeta Therapeutics, Inc.


Bradley_CharlesChuck Bradley, Vice President, Clinical Development, FibroGen, Inc.


Byrom_BillBill Byrom, Vice President, Product Strategy and Innovation, Signant Health


Xiaoyao_ConnyMoXiaoyao Conny Mo, MD, Partner, Lead of Medical Safety Consulting, Beijing Renheguangtong (RHGT) Co., Ltd. 


4:50  Chairperson’s Closing Remarks: Next Steps for Chinese, US, European and RoW Life Sci Companies to Further Partnerships in and with China
Zhao_SeanSean Zhao, PhD, Head, US Patient Safety, AstraZeneca


4:55  China Forum Ends, Transition to SCOPE Evening Keynote and Happy Hour

JOIN THE KICK-OFF KEYNOTE, PARTICIPANT ENGAGEMENT AWARD & HAPPY HOUR

keynotes

5:00 Evening Plenary Keynote Opening Remarks
Matt Miller, President, Co-Founder, StudyKIK
Micah Lieberman, Executive Director, Conferences, Cambridge Healthtech Institute (CHI)

5:05 INTERACTIVE PANEL: Taking the Plunge, Why Now is the Time to Invest in eConsent and Patient Engagement
Byrom_BillModerator: Bill Byrom, Vice President, Product Strategy and Innovation, Signant Health


5:40 SCOPE’s 2020 Participant Engagement Awards Introduction

Kim_Joe-2Joseph Kim, MBA, Senior Advisor, Patient Experience and Design Innovation, Eli Lilly


5:45 Participant Engagement Awards Introduction

SCOPE-Participant-Award-Header

In Memory of Jerry Matczak, #BeLikeJerry, #SCOPE2020
Creativity and Engagement in Recruitment and Retention Communications
Submit your work now: participant-engagement-award

6:20 SCOPE’S Kick-Off Networking Happy Hour    (Co-Sponsorship Opportunities Available)

7:30 Close of day (SCOPE Continues Wednesday, Thursday, Friday)


About SCOPE:
Celebrating its 11th successful year, SCOPE Summit 2020 takes place February 18-21 in Orlando, FL. SCOPE attracted more than 2,200 leaders in clinical operations and research in 2019 and we are expecting record attendance in 2020. Over the course of four stimulating days of in-depth discussions in 20 different conferences, 3 plenary keynote sessions, the annual Participant Engagement Awards, and the ever-popular interactive breakout discussions, the programming focuses on advances and innovative solutions in all aspects of clinical trial planning, management and operations, including: Site Selection and Management, Patient Engagement, Recruitment and Retention, Protocol Optimization, Feasibility, Data Strategy and Analytics, Sensors and Wearables, Project Management, Outsourcing, Forecasting, Budgeting and Contracting, Resource Management, Quality (QbD) in Trial Conduct, Risk-Based Monitoring, Artificial Intelligence, Post-Marketing Studies, Observational Research, Accessing and Generating RWD, Clinical Biomarker Strategy, Clinical Supply Chain, Precision Medicine, Clinical Biomarkers and Biospecimens, and Central Lab Solutions, and an all new track on Medical Device Clinical Trial Operations and Regulations. SCOPE is brought to you by Cambridge Innovation Institute (CII) and Cambridge Healthtech Institute (CHI), the organizers of Bio-IT World, AI World, Next Generation Diagnostics, PEGS, PepTalk, Discovery on Target and other events.


SCOPE 2019 attracts record attendance with more than 2,000 participants

A Leader in the Clinical Trial Industry: SCOPE Grows by 20% for the fourth consecutive year

2019 Event Features
  • 2,000+ participants
  • 19 conferences
  • Participant Engagement Awards
  • Dedicated Exhibit Hall Hours & Networking Functions
  • Interactive Breakout Discussions
  • Greater Gift Vaccine Dontations


The impressive executive audience at SCOPE came together for invaluable networking opportunities with more than 52% of the attendees titled as a decision maker from leading Pharma (20%), CRO (35%), and Biotech companies (20%). Industry leaders and key decision makers representing 28 different countries and more than 700 unique organizations shared case studies, collaborated on best practices and provided unique perspectives on poignant issues that the field currently faces.


2019 Attendee Demographics


* 活動內容有可能不事先告知作更動及調整。

Choose your language
Chinese
Japanese
Korean
English





Signature Sponsors

Almac

IQVIA_logo

medidatajoins3ds

Oracle-Health-Sciences

Saama-Technologies


免費電子郵件通知服務